{
  "@context": {
    "biotools": "https://bio.tools/ontology/",
    "bsc": "http://bioschemas.org/",
    "bsct": "http://bioschemas.org/types/",
    "dct": "http://purl.org/dc/terms/",
    "edam": "http://edamontology.org/",
    "rdf": "http://www.w3.org/1999/02/22-rdf-syntax-ns#",
    "rdfs": "http://www.w3.org/2000/01/rdf-schema#",
    "sc": "http://schema.org/",
    "xsd": "http://www.w3.org/2001/XMLSchema#"
  },
  "@graph": [
    {
      "@id": "https://bio.tools/geneva",
      "@type": "sc:SoftwareApplication",
      "dct:conformsTo": "https://bioschemas.org/profiles/ComputationalTool/0.6-DRAFT",
      "sc:additionalType": "Web application",
      "sc:applicationSubCategory": [
        {
          "@id": "edam:topic_0203"
        },
        {
          "@id": "edam:topic_3170"
        },
        {
          "@id": "edam:topic_3335"
        },
        {
          "@id": "edam:topic_3295"
        },
        {
          "@id": "edam:topic_3324"
        }
      ],
      "sc:citation": {
        "@id": "https://doi.org/10.1101/2020.10.20.20216150"
      },
      "sc:description": "Mining transcriptomics and clinical data reveals ACE2 expression modulators and identifies cardiomyopathy as a risk factor for mortality in COVID-19 patients.\n\nGENEVA allows you to identify RNA-sequencing datasets from the Gene Expression Omnibus (GEO) that contains conditions modulating a gene or a gene signature. See the Help page fore more detail.",
      "sc:featureList": [
        {
          "@id": "edam:operation_2495"
        },
        {
          "@id": "edam:operation_0224"
        },
        {
          "@id": "edam:operation_3223"
        }
      ],
      "sc:name": "GENEVA",
      "sc:url": "http://genevatool.org"
    },
    {
      "@id": "https://doi.org/10.1101/2020.10.20.20216150",
      "@type": "sc:CreativeWork"
    }
  ]
}